Clin2
NCT06595797Likely a fitNot yet recruiting

Study of HRS9531 Injection for PCOS with Obesity

Obese Subjects With Polycystic Ovary Syndrome (PCOS)

Treatments studied

Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.

This study tests an injection called HRS9531 to see if it helps women with PCOS who also have obesity. You will receive either the study drug or a placebo, and researchers will track weight and PCOS symptoms over time.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
144 people
Ages
18 years to 40 years
Study type
Interventional

Who can take part

  • Women aged 18 to 40 with a PCOS diagnosis
  • Body mass index (BMI) of 28 or higher
  • Weight has been stable (within 11 pounds) for at least 3 months with diet and exercise
  • Willing to use reliable birth control during the study
  • No major health issues like heart disease, uncontrolled blood pressure, severe depression, or recent surgery

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07350889Not yet recruiting
Dietary Program for Women with PCOS and Overweight

This study tests if a specific diet can help women with PCOS who are overweight. It looks at weight, hormone balance, and menstrual health over several months.

Beijing
NCT07690826Not yet recruiting· Phase 2
Study of HRS-4729 injection for weight loss in obesity

This trial tests an investigational injection called HRS-4729 for weight loss in people with obesity. It checks if the drug is safe and effective when used along with diet and exercise.

Shanghai, Shanghai Municipality
NCT07616037Recruiting· Phase 2
New hormone treatment for polycystic ovary syndrome

This study tests a new medication that combines two hormone-like drugs to treat polycystic ovary syndrome (PCOS), a condition affecting ovulation and hormone balance. The trial aims to see if this dual-action drug can improve irregular periods and other PCOS symptoms better than current treatments.

Shanghai, Shanghai Municipality
NCT06934408Recruiting· Phase 1
Safety study of HRS-5817 injection in healthy adults

This early-phase trial tests the safety and tolerability of a new injection called HRS-5817 in healthy volunteers. It helps researchers understand how the drug moves through the body and what side effects it might have.

Hefei, Anhui
NCT07559136Recruiting· Phase 1
Safety study of HRS9531 injection for teen obesity

This study tests whether a new injectable medication called HRS9531 is safe and well-tolerated in teenagers aged 12–17 with obesity. Researchers will monitor how your body handles the medication and whether it affects your weight.

Wuhan, Hubei
NCT03911297Recruiting
DAISy-PCOS study of hormone and metabolism in suspected PCOS

This study looks at hormone levels and metabolism in people who may have polycystic ovary syndrome (PCOS). It aims to better understand why PCOS happens, which could help improve future diagnosis and treatment.

Birmingham, West Midlands

Hear when a new Obese Subjects With Polycystic Ovary Syndrome (PCOS) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.